相关实验视频

Updated: May 6, 2026

Cecal Ligation Puncture Procedure

Cecal Ligation Puncture Procedure

Published on: May 7, 2011

脂质强化药物治疗败血症的第二阶段试点临床试验

Faheem W Guirgis¹, Lauren Page Black², Morgan Henson²

¹Department of Emergency Medicine, University of Florida College of Medicine, Gainesville, FL.

Critical care medicine

|March 15, 2024

概括

静脉输入的脂类乳液没有改变低胆固醇的败血症患者的胆固醇水平. 这项试点研究发现,小组之间48小时内总胆固醇变化没有显著差异.

科学领域:

关键护理医学关键护理医学
败血症病理生理学
脂质代谢脂质代谢是什么

背景情况:

早期败血症的低胆固醇水平与死亡率的增加有关.
了解干预措施来管理败血症中的脂质概况至关重要.

研究的目的:

评估静脉注射脂类乳液对败血症患者胆固醇水平的影响.
为了确定脂质乳液是否能防止胆固醇下降或在48小时后增加胆固醇水平.

主要方法:

一个II期,适应性,随机的试点临床试验,涉及48名败血症患者.
患有低胆固醇 (≤100 mg/dL总量或≤70 mg/dL HDL-C + LDL-C) 的患者接受了不同剂量的脂质乳液或安慰剂.
主要终点是从注册到48小时的血清总胆固醇的变化.

主要成果:

脂质乳液和对照组 (48小时后) 总胆固醇平均变化没有显著差异 (5 mg/dL与2 mg/dL,p=0.62).
在不同组之间,HDL-C和LDL-C的变化也相似.
在脂质乳液组 (p=0.086) 观察到三甘水平升高的趋势.
序列性器官衰竭评估 (SOFA) 评分在48小时后没有显示群体之间的显著差异.

结论:

静脉输入的脂质乳液给药没有影响低胆固醇早期败血症患者胆固醇水平的变化.
可能需要进一步的研究来探索替代策略来管理败血症中的脂质配置文件.

更多相关视频

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats

Published on: February 20, 2021

相关概念视频

Clinical Trials

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...

Acute Pyelonephritis II: Diagnostic Studies and Management

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...